From Healthcare & Pharma and USA - 12 Sep 2014 07:37 UTC UCB business attracts inversion interest Add to My Stories Print page Add to Favourites The sale by UCB, the Belgian pharmaceuticals business focusing on the treatment of disorders of the immune and central nervous systems, of its Kremers Urban Pharmaceuticals unit is understood to…